Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Linc	6ZB	28. nov 2024	6.43	+3.38
Lincoln Educational Services Corporation	K1L	28. nov 2024	15.60	+2.63
Lincoln Electric Holdings, Inc. -	LNE	28. nov 2024	204.00	-0.97
Lincoln National Corporation	LCO	28. nov 2024	33.15	-0.27
Lindab International	L5E	28. nov 2024	19.91	-1.44
Lindblad Expeditions Holdings Inc.	LI4	28. nov 2024	11.80	-1.67
Lindsay Corporation	LMF	28. nov 2024	123.60	-0.64
Linea Directa Aseguradora SA Cia de Seguros y Reaseguros	8I2	28. nov 2024	1.03	+3.52
Lineage Cell Therapeutics, Inc.	BT3	28. nov 2024	0.53	-6.25
Linedata Services SA	LN4	28. nov 2024	79.80	+0.25
Lingbao Gold Group Company Ltd	LI9	28. nov 2024	0.34	-3.41
Link Mobility Group Holding	L1N	28. nov 2024	1.99	+1.22
Link Real Estate Investment Trust Units	L5R	28. nov 2024	4.05	-0.59
Linklogis Inc	0NY	28. nov 2024	0.18	+0.55
Linmon Media Limited	8MN	28. nov 2024	0.36	0.00
Lintec Corporation	57T	28. nov 2024	18.80	+0.53
LINUS DIGITAL FINANCE AG	LDF	28. nov 2024	1.74	+0.58
Lion Copper and Gold Corp	QR20	28. nov 2024	0.04	-1.33
Lion Corporation	LOC	28. nov 2024	11.00	+0.92
Lion E-Mobility AG	LMIA	28. nov 2024	0.59	-9.92
Lion Electric Co (The)	70U	28. nov 2024	0.16	-5.54
Lion One Metals Ltd	LY1	28. nov 2024	0.20	+2.20
LION ROCK RES.INC.	KGB	28. nov 2024	0.08	+4.08
Lions Gate Entertainment Corp.	LGNB	28. nov 2024	7.00	+6.06
Lions Gate Entertainment Corporation Class A Voting Shares	LGNA	28. nov 2024	7.88	+5.84
Lipidor	L7R	28. nov 2024	0.00	-16.67
Lipigon Pharmaceuticals	9RP	28. nov 2024	0.00	0.00
LIPPO	LIP	28. nov 2024	0.07	0.00
Lippo Malls Indonesia Retail Trust Units	3HJ	28. nov 2024	0.01	0.00
Liquidia Corporation	LT4	28. nov 2024	10.92	+1.20

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.